Lack of regulation of 11β-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism

European Journal of Endocrinology

Volumn 161, Issue 3, 2009, Pages 375-380

  Sigurjonsdottir, Helga A ^a   Andrew, Ruth ^b   Stimson, Roland H ^b   Johannsson, Gudmundur ^a   Walker, Brian R ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CORTICOTROPIN; CORTISONE; CORTISONE ACETATE; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; MESSENGER RNA; PLACEBO; TESTOSTERONE; THYROXINE; HUMAN GROWTH HORMONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN DEFICIENCY; DRUG EFFECT; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME REGULATION; GROWTH HORMONE DEFICIENCY; HORMONE METABOLISM; HUMAN; HUMAN TISSUE; HYPOPHYSIS DISEASE; HYPOPITUITARISM; MALE; METABOLITE; MORNING DOSAGE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETREATMENT; SINGLE DRUG DOSE; SUBCUTANEOUS FAT; TREATMENT DURATION; URINE LEVEL; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE CALCULATION; GENE EXPRESSION REGULATION; GENETICS; HORMONE SUBSTITUTION; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT WITHDRAWAL; URINE; WHITE ADIPOSE TISSUE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE, WHITE; ADULT; AGED; DRUG DOSAGE CALCULATIONS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOCORTICOIDS; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOPITUITARISM; MALE; MIDDLE AGED; PLACEBOS; TIME FACTORS; WITHHOLDING TREATMENT; YOUNG ADULT;

EID: 70349245411     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0315     Document Type: Article

References (20)

1. Weaver JU, Thaventhiran L, Noonan K, Burrin JM, Taylor NF, Norman MR & Monson JP. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clinical Endocrinology 1994 41 639-648. (Pubitemid 24336867)
2. Moore JS, Monson JP, Kaltsas G, Putignano P, Wood PJ, Sheppard MC, Besser GM, Taylor NF & Stewart PM. Modulation of 11β-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. Journal of Clinical Endocrinology and Metabolism 1999 84 4172-4177. (Pubitemid 30644213)
3. Agha A & Monson JP. Modulation of glucocorticoid metabolism by the growth hormone-IGF-1 axis. Clinical Endocrinology 2007 66 459-465. (Pubitemid 46434930)
4. Giavoli C, Libe R, Corbetta S, Ferrante E, Lania A, Arosio M, Spada A & Beck-Peccoz P. Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients. Journal of Clinical Endocrinology and Metabolism 2004 89 5397-5401. (Pubitemid 39518415)
5. Gelding SV, Taylor NF, Wood PJ, Noonan K, Weaver JU, Wood DF & Monson JP. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11β-hydroxysteroid dehydrogenase activity. Clinical Endocrinology 1998 48 153-162. (Pubitemid 28091045)
6. Swords FM, Carroll PV, Kisalu J, Wood PJ, Taylor NF & Monson JP. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement. Clinical Endocrinology 2003 59 613-620. (Pubitemid 37357623)
7. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M & Stewart PM. Regulation of expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 2001 142 1982-1989. (Pubitemid 32405956)
8. Ricketts ML, Shoesmith KJ, Hewison M, Strain A, Eggo MC & Stewart PM. Regulation of 11β-hydroxysteroid dehydrogenase type 1 in primary cultures of rat and human hepatocytes. Journal of Endocrinology 1998 156 159-168. (Pubitemid 28049875)
9. Frajese GV, Taylor NF, Jenkins PJ, Besser GM & Monson JP. Modulation of cortisol metabolism during treatment of acromegaly is independent of body composition and insulin sensitivity. Hormone Research 2004 61 246-251.
10. Toogood AA, Taylor NF, Shalet SM & Monson JP. Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients. Journal of Clinical Endocrinology and Metabolism 2000 85 1727-1730. (Pubitemid 32289525)
11. Paulsen SK, Pedersen SB, Jorgensen JO, Fisker S, Christiansen JS, Flyvbjerg A & Richelsen B. Growth hormone (GH) substitution in GH-deficient patients inhibits 11β-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue. Journal of Clinical Endocrinology and Metabolism 2006 91 1093-1098. (Pubitemid 43357786)
12. Walker BR, Andrew R, MacLeod KM & Padfield PL. Growth hormone replacement inhibits renal and hepatic 11β-hydroxysteroid dehydrogenases in ACTH-deficient patients. Clinical Endocrinology 1998 49 257-263. (Pubitemid 28372657)
13. Trainer PJ, Drake WM, Perry LA, Taylor NF, Besser GM & Monson JP. Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2001 86 2989-2992. (Pubitemid 32673453)
14. Sigurjonsdottir HA, Koranyi J, Axelson M, Bengtsson BA & Johannsson G. GH effect on enzyme activity of 11βHSD in abdominal obesity is dependent on treatment duration. European Journal of Endocrinology 2006 154 69-74. (Pubitemid 43250738)
15. Tomlinson JW, Crabtree N, Clark PMS, Holder G, Toogood AA, Shackleton CHL & Stewart PM. Low-dose growth hormone inhibits 11β-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity. Journal of Clinical Endocrinology and Metabolism 2003 88 2113-2118. (Pubitemid 36549886)
16. Andrew R, Smith K, Jones GC & Walker BR. Distinguishing the activities of 11β-hydroxysteroid dehydrogenases in vivo using isotopically labelled cortisol. Journal of Clinical Endocrinology and Metabolism 2002 87 277-285. (Pubitemid 34084702)
17. Best R & Walker BR. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo. Clinical Endocrinology 1997 47 231-236. (Pubitemid 27359904)
18. Andrew R, Westerbacka J, Wahren J, Yki-Jarvinen H & Walker BR. The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans. Diabetes 2005 54 1364-1370. (Pubitemid 40586665)
19. Wake DJ, Stimson RH, Tan GD, Homer NZ, Andrew R, Karpe F & Walker BR. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11βeta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men. Journal of Clinical Endocrinology and Metabolism 2007 92 1848-1856. (Pubitemid 46997199)
20. Scolapio JS, Camilleri M, Fleming CR, Oenning LV, Burton DD, Sebo TJ, Batts KP & Kelly DG. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997 113 1074-1081. (Pubitemid 27418959)